(Fmoc-Glu⁷⁰,Ala⁷¹·⁷²,Lys⁷⁴)-C3a (70-77) |
| Catalog No.GA20180 |
The peptide Fmoc-EAALKLAR, which has been modeled after the C-terminus of the anaphylatoxin C3a, is a potent inhibitor of C3a activity. It is preferred for testing C3a-desensitizing capacity in vivo.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 145082-23-1
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
The peptide Fmoc-EAALKLAR, which has been modeled after the C-terminus of the anaphylatoxin C3a, is a potent inhibitor of C3a activity. It is preferred for testing C3a-desensitizing capacity in vivo.
Average Rating: 5 (Based on Reviews and 13 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *